Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on firstname.lastname@example.org
Global Chembio Diagnostics, Inc. (CEMI) - Product Pipeline Analysis, Update 2014
Chembio Diagnostics, Inc. (Chembio) together with its wholly owned subsidiary Chembio Diagnostic Systems, Inc., undertakes the development, manufacture and marketing of point-of-care diagnostic (POCs) tests that detect infectious diseases. The major commercially available products of the company include four rapid tests for the detection of HIV antibodies, two rapid tests for the detection of syphilis and a rapid test for the detection of canine leishmaniasis. Its new product pipeline is based on Dual Path Platform (DPP) technology. The company offers its products to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals and retailers. It also offers veterinary diagnostics. Chembio is headquartered in Medford, the US.
This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Chembio Diagnostics, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
Reasons to Buy: